Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults

Clinical trial NCT00264576 · COMPLETED

Trial details

NCT number: NCT00264576
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Disease; Flu

Start date: 2005-10-01
Primary completion: 2005-12-01
Enrollment: 613

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.